Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Burshtine currently holds 32,665 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Burshtine has been a net seller of OMRI stock. They have purchased $0 and sold $3.9M worth of shares.
Michael Burshtine's most recent insider trade was on Jan 4, 2008, when they sold 32,665 shares at $6.19 per share.
Michael Burshtine serves as Executive at Omrix Biopharmaceuticals, Inc. (OMRI). They have executed 9 insider transactions totaling $3.9M over their tenure at the company.
Michael Burshtine holds the position of Executive at Omrix Biopharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Michael Burshtine has shown a selling trading pattern, with $0 in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Burshtine was on Jan 2, 2008, when they sold $2.4M worth of OMRI shares. This transaction involved 70,091 shares at $34.45 per share.
Michael Burshtine currently owns 32,665 shares of Omrix Biopharmaceuticals, Inc. (OMRI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Burshtine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Burshtine has 9 Form 4 filings on record as an insider at Omrix Biopharmaceuticals, Inc..
Set alerts for Michael Burshtine and 40,000+ other insiders.